CFTR Modulators and Gastrointestinal Complications

CompletedOBSERVATIONAL
Enrollment

47,023

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

February 10, 2024

Study Completion Date

February 10, 2024

Conditions
Cystic FibrosisGastrointestinal System DiseaseDistal Intestinal Obstruction SyndromePancreatic Enzyme AbnormalityPancreatic DiseaseLung DiseasesDigestive System Disease
Interventions
OTHER

No intervention

Registry study: No intervention

Trial Locations (1)

NG7 2UH

Nottingham University Hospitals NHS Trust, Nottingham

All Listed Sponsors
collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

University of Washington

OTHER

collaborator

Seattle Children's Hospital

OTHER

lead

Nottingham University Hospitals NHS Trust

OTHER

NCT05253859 - CFTR Modulators and Gastrointestinal Complications | Biotech Hunter | Biotech Hunter